Login
← Go Back
Nectar Lifesciences
NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com
Stock Price vs Company Growth
1d
4.9%
1w
9.1%
1m
0.5%
3m
3.0%
6m
10.3%
1y
20.1%
5y
17.7%
10y
11.1%
all
1.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 11.1 4.9%
10
13.4
Company Overview
Sales
7.44 Cr
Growth: -11.8%
Profit after Tax
-280 Cr
Growth: -14.6%
Micro Cap
248 Cr
P/S: 28.9x
Industry P/S: 2.8x
Fundamentals
Sales (Cr) ₹ 7.44
Growth -11.8%
EBITDA N/A
P/S 28.9x
Dividend 0.0%
P/E N/A
Book Value ₹ 1
PEG Ratio N/A
ROE -1337.4%
P/B N/A
Shareholding Pattern
Institutions
Nsr Direct Pe Mauritius Llc
14.59 %
Ingain Traders, Llc
1.34 %
Iepf
0.02 %
Promoters
Sanjiv Goyal
31.33 %
Sanjiv (Huf)
24.47 %
Others
Increase    Decrease    No change
Company Profile Detailed
Nectar is a global pharmaceutical company specializing in Cephalosporins.
Investors (30)
religare...
f3.advis...
nisarg.v...
Followers (2)
bhaskar6
sanjayda...